UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 163

Sortiert nach

Role of P-glycoprotein in Statin Drug Interactions

Pharmacotherapy, 2006-11, Vol.26 (11), p.1601-1607

2006

Link zum Volltext

Verfügbarkeit prüfen

Intraosseous drug administration in children and adults during cardiopulmonary resuscitation

The Annals of pharmacotherapy, 2007-10, Vol.41 (10), p.1679

2007

Link zum Volltext

Verfügbarkeit prüfen

Human Angiopoietin-like Protein 3/ANGPTL3 Antibodies: Adding to the Armamentarium in the Management of Dyslipidemia

Journal of cardiovascular pharmacology, 2021-11, Vol.78 (5), p.e631

Wiggins, Barbara S

2021

Link zum Volltext

Verfügbarkeit prüfen

Select Drug-Drug Interactions With Direct Oral Anticoagulants: JACC Review Topic of the Week

Journal of the American College of Cardiology, 2020-03, Vol.75 (11), p.1341

2020

Link zum Volltext

Verfügbarkeit prüfen

2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways

Journal of the American College of Cardiology, 2017-12, Vol.70 (24), p.3042-3067

2017

Link zum Volltext

Verfügbarkeit prüfen

2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee

Journal of the American College of Cardiology, 2020-08, Vol.76 (5), p.594

2020

Link zum Volltext

Verfügbarkeit prüfen

2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents

Journal of the American College of Cardiology, 2018-12, Vol.72 (25), p.3332-3365

2018

Link zum Volltext

Verfügbarkeit prüfen

Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association

Circulation (New York, N.Y.), 2016-11, Vol.134 (21), p.e468-e495

2016

Link zum Volltext

Verfügbarkeit prüfen

Statin‐associated muscle symptoms—A review: Individualizing the approach to optimize care

Pharmacotherapy, 2022-05, Vol.42 (5), p.428-438

2022

Link zum Volltext

Verfügbarkeit prüfen

2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants

Journal of the American College of Cardiology, 2017-12, Vol.70 (24), p.3042-3067

2017

Link zum Volltext

Verfügbarkeit prüfen

Select drug-drug interactions with colchicine and cardiovascular medications: A review

The American heart journal, 2022-10, Vol.252, p.42-50

2022

Link zum Volltext

Verfügbarkeit prüfen

Reduced Anticoagulant Effect of Dabigatran in a Patient Receiving Concomitant Phenytoin

Pharmacotherapy, 2016-02, Vol.36 (2), p.e5-e7

2016

Link zum Volltext

Verfügbarkeit prüfen

Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review

Advances in therapy, 2020-02, Vol.37 (2), p.656-670

2020

Link zum Volltext

Verfügbarkeit prüfen

2023 Atrial Fibrillation Guideline-at-a-Glance

Journal of the American College of Cardiology, 2024-01, Vol.83 (1), p.280-284

2024

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness and Safety of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation and Weighing ≥ 120 Kilograms versus 60–120 Kilograms

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2021-09, Vol.21 (5), p.545-551

2021

Link zum Volltext

Verfügbarkeit prüfen

Evolocumab: Considerations for the Management of Hyperlipidemia

Current atherosclerosis reports, 2018-04, Vol.20 (4), p.17-17, Article 17

2018

Link zum Volltext

Verfügbarkeit prüfen

A Response to: Letter to the Editor Regarding “Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: a Narrative Review”

Advances in therapy, 2020-09, Vol.37 (9), p.4046-4048

2020

Link zum Volltext

Verfügbarkeit prüfen

UPPING THE ANTE ON HEPARIN DOSING: IS IT TIME FOR A CHANGE IN THE MANAGEMENT OF CARDIOVASCULAR PATIENTS IN THE OBESITY ERA?

Journal of the American College of Cardiology, 2016-04, Vol.67 (13), p.533-533

2016

Link zum Volltext

Verfügbarkeit prüfen

Key Articles and Guidelines in the Management of Dyslipidemia: 2019 Update

Journal of pharmacy practice, 2020-12, Vol.33 (6), p.882-894

2020

Link zum Volltext

Verfügbarkeit prüfen

Recommendations for Managing Drug–Drug Interactions with Statins and HIV Medications

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2017-10, Vol.17 (5), p.375-389

2017

Link zum Volltext

Verfügbarkeit prüfen

Discharge Counseling for Patients with Heart Failure or Myocardial Infarction: A Best Practices Model Developed by Members of the American College of Clinical Pharmacy's Cardiology Practice and Research Network Based on the Hospital to Home (H2H) Initiative

Pharmacotherapy, 2013-05, Vol.33 (5), p.558-580

2013

Link zum Volltext

Verfügbarkeit prüfen

Gemfibrozil in Combination with Statins—Is It Really Contraindicated?

Current atherosclerosis reports, 2016-04, Vol.18 (4), p.18, Article 18

2016

Link zum Volltext

Verfügbarkeit prüfen

Postoperative Antibiotic Prophylaxis Following Cardiac Implantable Electronic Device Placement

The Journal of innovations in cardiac rhythm management (Print), 2019-08, Vol.10 (8), p.3777-3784

2019

Link zum Volltext

Verfügbarkeit prüfen

Higher Maximum Doses and Infusion Rates Compared with Standard Unfractionated Heparin Therapy Are Associated with Adequate Anticoagulation without Increased Bleeding in Both Obese and Nonobese Patients with Cardiovascular Indications

Pharmacotherapy, 2017-04, Vol.37 (4), p.393-400

2017

Link zum Volltext

Verfügbarkeit prüfen

2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging: Best Practices for Safety and Effectiveness

Catheterization and cardiovascular interventions, 2018-08, Vol.92 (2), p.E35-E97

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 163

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(152)
Mit Volltextzugriff
(138)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(162)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Role of P-glycoprotein in Statin Drug Interactions

Intraosseous drug administration in children and adults during cardiopulmonary resuscitation

Human Angiopoietin-like Protein 3/ANGPTL3 Antibodies: Adding to the Armamentarium in the Management of Dyslipidemia

Select Drug-Drug Interactions With Direct Oral Anticoagulants: JACC Review Topic of the Week

2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways

2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee

2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents

Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association

Statin‐associated muscle symptoms—A review: Individualizing the approach to optimize care

2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants

Select drug-drug interactions with colchicine and cardiovascular medications: A review

Reduced Anticoagulant Effect of Dabigatran in a Patient Receiving Concomitant Phenytoin

Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review

2023 Atrial Fibrillation Guideline-at-a-Glance

Effectiveness and Safety of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation and Weighing ≥ 120 Kilograms versus 60–120 Kilograms

Evolocumab: Considerations for the Management of Hyperlipidemia

A Response to: Letter to the Editor Regarding “Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: a Narrative Review”

UPPING THE ANTE ON HEPARIN DOSING: IS IT TIME FOR A CHANGE IN THE MANAGEMENT OF CARDIOVASCULAR PATIENTS IN THE OBESITY ERA?

Key Articles and Guidelines in the Management of Dyslipidemia: 2019 Update

Recommendations for Managing Drug–Drug Interactions with Statins and HIV Medications

Discharge Counseling for Patients with Heart Failure or Myocardial Infarction: A Best Practices Model Developed by Members of the American College of Clinical Pharmacy's Cardiology Practice and Research Network Based on the Hospital to Home (H2H) Initiative

Gemfibrozil in Combination with Statins—Is It Really Contraindicated?

Postoperative Antibiotic Prophylaxis Following Cardiac Implantable Electronic Device Placement

Higher Maximum Doses and Infusion Rates Compared with Standard Unfractionated Heparin Therapy Are Associated with Adequate Anticoagulation without Increased Bleeding in Both Obese and Nonobese Patients with Cardiovascular Indications

2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging: Best Practices for Safety and Effectiveness

Suchergebnisse filtern